key words: bronchial asthma, cysteinyl leukotriene (cysLT), LTB4, 5-lipoxygenase, LTC4 synthase Summary Cysteinyl leukotrienes (cysLTs), arachidonate 5-lipoxygenase products, play significant roles in the pathogenesis of bronchial asthma in children. In these 15 years several lines of evidence have demonstrated that the production of cysLTs is controlled by molecular mechanisms induced by external and internal bioactive substances.
Conversion rate of LTC4 to LTE4
in asthmatic children:
Catabolism of LTC4 to less bioactive LTE4 is another important aspect in determining the action of cysLTs. We examined enzyme-activity in sera which converts LTC4 to LTE4 in the patients with asthma and compared it with that in control subjects. Externally added authentic LTC4 was incubated for 30 min with sera obtained from patients or control subjects, and the levels of LTC4 and LTE4 were measured by HPLC. In the patients with asthma, the level of LTC4 was higher than that in the controls, and the level of LTE4 was lower than that of the controls, indicating that the conversion of LTC4 to LTE4 was decreased in asthmatic patients18.
Action of GCS in catabolic pathway of cysLTs:
Catabolic pathway of LTC4 to LTE4 is an important aspect to consider asthma treatment, because LTE4 is biologically less active than LTC4 and LTD4. LTC4 is converted to LTD4 by GTPRE, and then further metabolized to LTE4 by dipeptidase. (fig 2) We examined whether glucocorticosteroid(GCS) and other anti-asthma drugs have any pharmacological effects on the activities of these catabolic enzymes in transformed human bronchoepithelial cells (16HBE cells). 16HBE cells were incubated with or without GCS for 2 days, then authentic LTC4 was added into the medium. Conversion of LTC4 to LTE4 via LTD4 was measured by HPLC. GCS treatment increases LTC4 catabolic activity to LTE4. The same activity was examined in the presence of salbutamol and DSCG. Salbutamol and DSCG did not increase LTC4 catabolism. Only GCS accelerated the conversion of externally added LTC4 to LTD4 and LTE4. In order to clarify the molecular mechanisms of this acceleration, mRNA expression of catabolic enzymes, gamma glutamyl transpeptidase and GTPRE was examined by RT-PCR. Messenger RNA expression of GTPRE was enhanced, indicating that GCS attenuated bioactivities of cysteinyl LTs by transcriptionally up-reguating GTPRE, a catabolic enzyme19).
Discussion and conclusion
We demonstrated that production of cysLTs and LTB4 in the airway was increased in acute asthma, and the productivity of cysLTs in peripheral PMNs was enhanced by molecular mechanisms of LT-synthetic enzymes, 5-LO, LTA4 hydrolase and LTC4 synthase. 
